Volume 25, Issue 1 , 2025
Redirecting Research to Alzheimer's Disease
Pp: 1-2
Author(s): Ramón Cacabelos
DOI: 10.2174/187152492501241014100836
Published on: 14 October, 2024
Nanomedicine: A New Frontier in Alzheimer’s Disease Drug Targeting
Pp: 3-19
Author(s): Kalyani Pathak*, Mohammad Zaki Ahmad, Riya Saikia, Manash Pratim Pathak, Jon Jyoti Sahariah, Parimita Kalita, Aparoop Das, Md Ariful Islam, Pallab Pramanik, Dubom Tayeng and Basel A. Abdel-Wahab
DOI: 10.2174/0118715249281331240325042642
Published on: 28 March, 2024
The Role of Nanotechnology in Understanding the Pathophysiology of Traumatic Brain Injury
Pp: 20-38
Author(s): Saranya Selvaraj and Laksiri Weerasinghe*
DOI: 10.2174/0118715249291999240418112531
Published on: 25 April, 2024
Beta-site APP-cleaving Enzyme-1 Inhibitory Role of Natural Flavonoids in the Treatment of Alzheimer's Disease
Pp: 39-48
Author(s): Sandeep Singh, Virendra Kushwaha, Shriram Sisodia, Shivendra Kumar and Kantrol Kumar Sahu*
DOI: 10.2174/0118715249315049240710063455
Published on: 12 July, 2024
A Review of the Association between Infections, Seizures, and Drugs
Pp: 49-55
Author(s): Zahra Tolou-Ghamari*
DOI: 10.2174/0118715249288932240416071636
Published on: 25 April, 2024
Filtration of Natural Derivatives as MAO Inhibitors by Virtual Screening: A Potential Lead for Neurodegenerative Disorders
Pp: 56-67
Author(s): Neelam Malik, Supriya Agnihotri and Priyanka Dhiman*
DOI: 10.2174/0118715249284642240326045923
Published on: 04 April, 2024
A Computational Study of Phenothiazine Derivatives as Acetylcholinesterase Inhibitors Targeting Alzheimer’s Disease
Pp: 68-82
Author(s): Prema V.*, Meena A. and Ramalakshmi N.
DOI: 10.2174/0118715249300784240430110628
Published on: 16 May, 2024
